Patents by Inventor J. Gregory Cairncross

J. Gregory Cairncross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4806628
    Abstract: Monoclonal antibodies were discovered which recognize differentiation antigens on melanocytes and melanoma cells at various stages of differentiation. A system of classification based on these antigens is proposed and their use in the diagnosis and treatment of melanoma is given.
    Type: Grant
    Filed: March 17, 1986
    Date of Patent: February 21, 1989
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Anthony Albino, J. Gregory Cairncross, Magdalena Eisinger, Alan N. Houghton, Lloyd Old
  • Patent number: 4642291
    Abstract: Method of forming an antibody producing hybridoma cell line by fusing a myeloma cell line with splenocytes derived from BALB/c mice immunized with human astrocytoma tumor cells, the hybridoma cell line formed, and the monoclonal antibodies generated by said hybridoma cell line. A method of phenotyping astrocytoma tumor cells comprising determining the reaction of said cells to various monoclonal antibodies to astrocytoma tumor cells is also provided.
    Type: Grant
    Filed: September 1, 1982
    Date of Patent: February 10, 1987
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: J. Gregory Cairncross, M. Jules Mattes, H. Richard Beresford, Anthony P. Albino, Alan N. Houghton, Kenneth O. Lloyd, Lloyd J. Old